Continuity Biosciences
Bradenton, US · Founded 2023 · Delaware LLC · 1 known investors
Biotech
Founders & leadership
RW
Robert WhiteheadExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$8.4MraisedAug 2025 · 13 investors · BiotechnologyRule 506(b)
▶$8.4MraisedAug 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael L. FowlerDirector
- Allen R. WeissDirector
- Monica P. ReedDirector
- Joseph DeSimoneDirector
- Ramakrishna VenugopalanExecutive Officer, Director
- Robert WhiteheadDirector
- Josephine TorrenteDirector
- Offering amount
- $12M
- Amount sold
- $8.4M
- First sale
- Aug 2025
- Incorporated
- Limited Liability Company, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedJun 2025 · 13 investors · BiotechnologyRule 506(b)
▶$1MraisedJun 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ramakrishna VenugopalanExecutive Officer, Director
- Robert WhiteheadDirector
- Allen R. WeissDirector
- Michael L. FowlerDirector
- Monica P. ReedDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- May 2025
- Incorporated
- Limited Liability Company, Delaware, 2023
- Federal exemptions
- 06b
▶$2.5MraisedJul 2024 · 10 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJul 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert WhiteheadExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.5M
- First sale
- Jun 2024
- Incorporated
- Limited Liability Company, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.